We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Committee Recommends Approval of Opioid Withdrawal Drug
FDA Committee Recommends Approval of Opioid Withdrawal Drug
The Psychopharmacologic Drugs Advisory Committee voted to recommend approval of an NDA for lofexidine hydrochloride for mitigation of opioid withdrawal symptoms.